tailieunhanh - Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on corticosteroids and/or immunomodulators. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN